Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 190.75-6.18-66.140.2217.80

What is the latest EBIT Growth ratio of GLENMARK PHARMACEUTICALS ?

The latest EBIT Growth ratio of GLENMARK PHARMACEUTICALS is 190.75 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025190.75
Mar2024-6.18
Mar2023-66.14
Mar20220.22
Mar202117.80

How is EBIT Growth of GLENMARK PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 190.75
Positive
Mar2024 -6.18
Negative
Mar2023 -66.14
Negative
Mar2022 0.22
-98.76
Mar2021 17.8 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EBIT Growth ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹62,920.7 Cr 1.6% 2.5% 63.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,209.0 Cr 1% -6.4% -0.7% Stock Analytics
DIVIS LABORATORIES ₹166,750.0 Cr 3.5% 3.4% 11.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,746.0 Cr 0.2% -1.8% 33.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,851.0 Cr -0.2% -3.4% 11.4% Stock Analytics
CIPLA ₹99,268.4 Cr 1.5% -5.4% -15.4% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.6%

2.5%

63.2%

SENSEX

1.3%

5.3%

6.3%


You may also like the below Video Courses